List of insiders holdings for ACURA PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Schutte John 10% Owner | 2021-06-28 11:17:56 | 52,984,375 0 | 52,984,375 | Form 13D |
| Abuse Deterrent Pharma LLC 10% Owner | 2021-06-28 11:00:40 | 44,766,906 0 | 44,766,906 | Form 4 |
| GCE Holdings LLC 10% Owner | 2012-10-03 16:31:14 | 32,511,464 0 | 32,511,464 | Form 4 |
| CARE CAPITAL II LLC CARE CAPITAL INVESTMENTS II LP Care Capital Offshore Investments II LP Ramsay David Russ 10% Owner | 2012-12-27 13:37:28 | 10,742,398 0 | 10,742,398 | Form 13D |
| REICHER MICHAEL K former director and officer Director | 2003-12-02 15:34:06 | 3,797,037 0 | 3,797,037 | Form 4 |
| THANGARAJ IMMANUEL Director | 2024-01-02 15:20:34 | 497,647 1,956,396 | 2,454,043 | Form 4 |
| ESSEX WOODLANDS HEALTH VENTURES FUND V LP 10% Owner | 2022-02-14 12:54:52 | 2,287,377 0 | 2,287,377 | Form 13D |
| ESSEX WOODLANDS HEALTH VENTURES FUND V LLC ESSEX WOODLANDS HEALTH VENTURES FUND V LP 10% Owner | 2022-02-14 12:54:52 | 2,287,377 0 | 2,287,377 | Form 13D |
| REDDICK ANDREW D President and CEO | 2011-04-06 12:05:49 | 1,374,846 0 | 1,374,846 | Form 4 |
| WESSON BRUCE F Director Emeritus | 2024-01-02 15:20:14 | 842,048 0 | 842,048 | Form 4 |
| Jones Robert B President & CEO | 2023-11-20 12:08:01 | 643,555 0 | 643,555 | Form 4 |
| SKELLY WILLIAM G Director | 2024-01-02 15:23:09 | 625,989 0 | 625,989 | Form 4 |
| ROSS GEORGE K Director | 2024-01-02 15:23:43 | 545,503 0 | 545,503 | Form 4 |
| CLEMENS PETER A Senior VP & CFO | 2023-11-20 12:07:34 | 545,430 0 | 545,430 | Form 4 |
| Brzeczko Albert W See Remarks | 2023-11-20 12:07:02 | 486,001 0 | 486,001 | Form 4 |
| EMIGH JAMES F VP, Corporate Development | 2021-02-26 16:11:10 | 474,042 0 | 474,042 | Form 4 |
| SMITH ALAN J Director term exp Aug 12, 2004 | 2004-08-13 12:01:27 | 445,694 0 | 445,694 | Form 4 |
| Seiser Robert A VP, Treasurer & Controller | 2023-11-20 12:08:30 | 438,254 0 | 438,254 | Form 4 |
| SPIVEY RON J Sr VP/Chief Scientific Officer | 2008-05-23 17:26:48 | 160,000 0 | 160,000 | Form 4 |
| SUMNER WILLIAM Director | 2011-01-03 18:42:20 | 134,924 0 | 134,924 | Form 4 |
| Boehm Garth VP Mod. Rel. Dosage Form Dev. | 2009-05-12 09:04:16 | 120,000 0 | 120,000 | Form 4 |
| Markham Richard J Director | 2013-01-03 14:16:08 | 15,000 0 | 15,000 | Form 4 |
| Azad David Director | 2012-01-03 17:12:41 | 15,000 0 | 15,000 | Form 4 |
| Rivet J Bradley VP Marketing | 2016-12-12 16:10:23 | 14,000 0 | 14,000 | Form 4 |
| CLAUDIUS LLC GALEN PARTNERS INTERNATIONAL III L P GALEN EMPLOYEE FUND III LP Galen Management LLC GALEN PARTNERS III L P Former 10% owner | 2018-01-02 18:11:59 | 0 0 | 0 | Form 4 |
| CARE CAPITAL II LLC CARE CAPITAL INVESTMENTS II LP Care Capital Offshore Investments II LP 10% Owner | 2017-01-25 16:56:50 | 0 0 | 0 | Form 13D |